> with the exception of Frist a quick read shows no connection to healthcare

Well, there's also Shultz, who was "a director at biopharmaceutical company Gilead Sciences," according to this article.

But you're right that those people are mainly on the board for their influence in Washington. The importance of that when taking on an entrenched and heavily regulated industry can't be overstated.